Peak Retirement Planning Inc. Acquires Shares of 40,103 Option Care Health, Inc. (NASDAQ:OPCH)

Peak Retirement Planning Inc. purchased a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 40,103 shares of the company's stock, valued at approximately $1,026,000.

A number of other hedge funds have also modified their holdings of OPCH. JPMorgan Chase & Co. raised its holdings in Option Care Health by 29.6% during the fourth quarter. JPMorgan Chase & Co. now owns 1,511,403 shares of the company's stock valued at $35,065,000 after buying an additional 344,875 shares in the last quarter. MetLife Investment Management LLC raised its stake in shares of Option Care Health by 7.8% in the 4th quarter. MetLife Investment Management LLC now owns 197,219 shares of the company's stock valued at $4,575,000 after acquiring an additional 14,311 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its position in Option Care Health by 6.2% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company's stock worth $58,235,000 after purchasing an additional 147,054 shares during the period. Global Alpha Capital Management Ltd. grew its holdings in Option Care Health by 38.1% during the fourth quarter. Global Alpha Capital Management Ltd. now owns 68,810 shares of the company's stock valued at $1,596,000 after purchasing an additional 18,992 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd bought a new position in shares of Option Care Health in the fourth quarter valued at approximately $327,000. 98.05% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. JMP Securities reaffirmed a "market outperform" rating and issued a $36.00 target price on shares of Option Care Health in a report on Tuesday, April 22nd. UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their target price for the company from $38.00 to $40.00 in a research note on Wednesday, April 30th. JPMorgan Chase & Co. raised their price target on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. Finally, Barrington Research reaffirmed an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a research report on Wednesday, April 30th. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $35.50.

Option Care Health Price Performance

Option Care Health stock traded up $0.71 during mid-day trading on Tuesday, hitting $32.12. 827,855 shares of the company were exchanged, compared to its average volume of 1,858,791. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The business has a fifty day moving average of $32.93 and a 200 day moving average of $29.45. The company has a market capitalization of $5.26 billion, a PE ratio of 26.99, a price-to-earnings-growth ratio of 2.30 and a beta of 0.76.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, topping analysts' consensus estimates of $0.36 by $0.04. The company had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.26 billion. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The company's revenue was up 16.3% on a year-over-year basis. During the same period in the previous year, the firm posted $0.26 earnings per share. As a group, sell-side analysts expect that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Insider Buying and Selling

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. The trade was a 40.80% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.64% of the stock is currently owned by insiders.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.